International Society for Cellular Therapy

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics

Jonathan-Kimmelman-FDA-e1473490111453

The FDA is holding its first 2016 stem cell meeting today and you can read about some impressions of the morning session of this meeting here. In this post, I’m focusing on the afternoon session, which has been mostly on policy and ethics, including on stem cell clinics. Jonathan Kimmelman from McGill University got the afternoon going …

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics Read More »

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces

FDAADF

The FDA in the past year or so has issued draft guidances on regulation of stem cells that would, if finalized, make it crystal clear that what many American stem cell clinics are selling are unapproved drugs. That would be a good thing for patients who are often being put at risk by many of …

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces Read More »